The bioreactor made to measure for start-ups and universities arrives which takes the biotechnology sector a new leap forward. The system – a new born from Research & Development, is called One, is made in Italy and is aimed at startups, private research bodies and even universities. One is fully automated with integrated WiFi connection designed for basic research activities and for smaller scale productions, more accessible, therefore, in terms of costs, use and maintenance. To realize this new technology was Solaris Biotechnology – recently joined the Donaldson Company group – which for twenty years has specialized in design and development in the biotechnology field.
In short, the pandemic has not stopped biotech. On the contrary. The players in the sector are increasing and in the future there will be more and more areas of activity and application, in line with the growing needs of the population, especially in the medical and food fields, according to the latest report presented last July by Federchimica and Assobiotech which highlighted how investments in research and development have not stopped and how innovative startups have registered a growth of 20%. And One “was created precisely to respond to the growing demand for new cutting-edge and economically accessible solutions by startups” underline the company.
“Biotech – they explain – is today an asset on which countries cannot fail to aim for an economic restart that is also sustainable. Our company has always been attentive to the development of solutions tailored to the customer’s production needs: from large plants to small-scale laboratory bioreactors “.
“With One we want to give the most up-to-date and avant-garde answer within our range of products: it is, in fact, a precise and performing bioreactor, but at the same time more accessible from the point of view of economic investment “they add from the company which has its administrative and production headquarters in the province of Mantua, owns two commercial and service offices in the San Francisco Bay, California, and Kuala Lumpur, Malaysia, as well as a network of local representatives in more than 40 countries around the world.
Precisely to meet not only the application needs, but also the economic needs of companies, Solaris Biotecnology has also provided for the possibility of “purchase through a monthly loan”. Founded in 2002, Solaris Biotechnology is an Italian company engaged in the creation of biotech solutions for cGmp applications at industrial and r & d level. The production specializes in the construction of fermenters, bioreactors, reactors, Cip and Sip systems, gas analyzers, process tanks and Tangential Filtration (Tff) systems. “The great experience and constant study also allows Solaris operators to create real ‘turnkey’ solutions, for the construction of complete production plants, made to measure according to the needs of the individual customer” he finally adds.